421 related articles for article (PubMed ID: 36528193)
1. Hybrid exosomes, exosome-like nanovesicles and engineered exosomes for therapeutic applications.
Mondal J; Pillarisetti S; Junnuthula V; Saha M; Hwang SR; Park IK; Lee YK
J Control Release; 2023 Jan; 353():1127-1149. PubMed ID: 36528193
[TBL] [Abstract][Full Text] [Related]
2. Current strategies in tailoring methods for engineered exosomes and future avenues in biomedical applications.
Mishra A; Singh P; Qayoom I; Prasad A; Kumar A
J Mater Chem B; 2021 Aug; 9(32):6281-6309. PubMed ID: 34286815
[TBL] [Abstract][Full Text] [Related]
3. Engineered Exosomes for Tumor-Targeted Drug Delivery: A Focus on Genetic and Chemical Functionalization.
Akbari A; Nazari-Khanamiri F; Ahmadi M; Shoaran M; Rezaie J
Pharmaceutics; 2022 Dec; 15(1):. PubMed ID: 36678695
[TBL] [Abstract][Full Text] [Related]
4. Engineering exosomes as refined biological nanoplatforms for drug delivery.
Luan X; Sansanaphongpricha K; Myers I; Chen H; Yuan H; Sun D
Acta Pharmacol Sin; 2017 Jun; 38(6):754-763. PubMed ID: 28392567
[TBL] [Abstract][Full Text] [Related]
5. Exosomes: Cell-Derived Nanoplatforms for the Delivery of Cancer Therapeutics.
Kim H; Kim EH; Kwak G; Chi SG; Kim SH; Yang Y
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374978
[TBL] [Abstract][Full Text] [Related]
6. Plant Exosome-like Nanovesicles: Emerging Therapeutics and Drug Delivery Nanoplatforms.
Dad HA; Gu TW; Zhu AQ; Huang LQ; Peng LH
Mol Ther; 2021 Jan; 29(1):13-31. PubMed ID: 33278566
[TBL] [Abstract][Full Text] [Related]
7. Engineered and Mimicked Extracellular Nanovesicles for Therapeutic Delivery.
Poinsot V; Pizzinat N; Ong-Meang V
Nanomaterials (Basel); 2024 Apr; 14(7):. PubMed ID: 38607173
[TBL] [Abstract][Full Text] [Related]
8. Exosome-based nanocarriers as bio-inspired and versatile vehicles for drug delivery: recent advances and challenges.
Zhang M; Zang X; Wang M; Li Z; Qiao M; Hu H; Chen D
J Mater Chem B; 2019 Apr; 7(15):2421-2433. PubMed ID: 32255119
[TBL] [Abstract][Full Text] [Related]
9. Encapsulation and assessment of therapeutic cargo in engineered exosomes: a systematic review.
Chen Z; Xiong M; Tian J; Song D; Duan S; Zhang L
J Nanobiotechnology; 2024 Jan; 22(1):18. PubMed ID: 38172932
[TBL] [Abstract][Full Text] [Related]
10. Cell-free synthesis of connexin 43-integrated exosome-mimetic nanoparticles for siRNA delivery.
Lu M; Zhao X; Xing H; Liu H; Lang L; Yang T; Xun Z; Wang D; Ding P
Acta Biomater; 2019 Sep; 96():517-536. PubMed ID: 31284098
[TBL] [Abstract][Full Text] [Related]
11. Purposing plant-derived exosomes-like nanovesicles for drug delivery: patents and literature review.
Orefice NS; Di Raimo R; Mizzoni D; Logozzi M; Fais S
Expert Opin Ther Pat; 2023 Feb; 33(2):89-100. PubMed ID: 36947052
[TBL] [Abstract][Full Text] [Related]
12. Artificial exosomes for translational nanomedicine.
Li YJ; Wu JY; Liu J; Xu W; Qiu X; Huang S; Hu XB; Xiang DX
J Nanobiotechnology; 2021 Aug; 19(1):242. PubMed ID: 34384440
[TBL] [Abstract][Full Text] [Related]
13. FedExosomes: Engineering Therapeutic Biological Nanoparticles that Truly Deliver.
Marcus ME; Leonard JN
Pharmaceuticals (Basel); 2013; 6(5):659-80. PubMed ID: 23894228
[TBL] [Abstract][Full Text] [Related]
14. Bioinspired exosome-like therapeutics and delivery nanoplatforms.
Lu M; Huang Y
Biomaterials; 2020 Mar; 242():119925. PubMed ID: 32151860
[TBL] [Abstract][Full Text] [Related]
15. Exosomes as Drug Delivery Systems: Endogenous Nanovehicles for Treatment of Systemic Lupus Erythematosus.
Ortega A; Martinez-Arroyo O; Forner MJ; Cortes R
Pharmaceutics; 2020 Dec; 13(1):. PubMed ID: 33374908
[TBL] [Abstract][Full Text] [Related]
16. Macrophage-derived exosome-mimetic hybrid vesicles for tumor targeted drug delivery.
Rayamajhi S; Nguyen TDT; Marasini R; Aryal S
Acta Biomater; 2019 Aug; 94():482-494. PubMed ID: 31129363
[TBL] [Abstract][Full Text] [Related]
17. Engineering blood exosomes for tumor-targeting efficient gene/chemo combination therapy.
Zhan Q; Yi K; Qi H; Li S; Li X; Wang Q; Wang Y; Liu C; Qiu M; Yuan X; Zhao J; Hou X; Kang C
Theranostics; 2020; 10(17):7889-7905. PubMed ID: 32685027
[No Abstract] [Full Text] [Related]
18. Advances in exosome therapies in ophthalmology-From bench to clinical trial.
Sanghani A; Andriesei P; Kafetzis KN; Tagalakis AD; Yu-Wai-Man C
Acta Ophthalmol; 2022 May; 100(3):243-252. PubMed ID: 34114746
[TBL] [Abstract][Full Text] [Related]
19. Exosome engineering for efficient and targeted drug delivery: Current status and future perspective.
Malekian F; Shamsian A; Kodam SP; Ullah M
J Physiol; 2023 Nov; 601(22):4853-4872. PubMed ID: 35570717
[TBL] [Abstract][Full Text] [Related]
20. Exploitation of Exosomes as Nanocarriers for Gene-, Chemo-, and Immune-Therapy of Cancer.
Srivastava A; Babu A; Filant J; Moxley KM; Ruskin R; Dhanasekaran D; Sood AK; McMeekin S; Ramesh R
J Biomed Nanotechnol; 2016 Jun; 12(6):1159-73. PubMed ID: 27319211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
